Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Drug Target for Breast Cancer Identified

May 23, 2011 7:56 am | News | Comments

Researchers at Imperial College London have identified a new protein involved in the development of drug resistance in breast cancer that could be a target for new treatments.


Cephalon Wins Restraining Order Against Mylan

May 23, 2011 7:52 am | News | Comments

FRAZER, Pa. (AP) - Drugmaker Cephalon Inc. reported on May 20 that a U.S. district court judge granted its request for a restraining order barring Mylan Inc. from launching a generic version of the muscle relaxant Amrix.


Sutent Approved for Pancreatic Tumors

May 23, 2011 7:48 am | News | Comments

Pfizer Inc. announced the U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) as the first anti-VEGF therapy to treat progressive pancreatic neuroendocrine tumors (NET) in patients with locally advanced or metastatic disease.


FDA Expands Pfizer Drug Approval for Rare Cancer

May 23, 2011 7:25 am | News | Comments

WASHINGTON (AP) - The Food and Drug Administration (FDA) expanded approval of a Pfizer drug to treat a rare form of pancreatic cancer.


Auxilium Gets $7.5M Payment from Pfizer for Xiapex

May 23, 2011 7:20 am | News | Comments

MALVERN, Pa. (AP) - Auxilium Pharmaceuticals Inc. received a $7.5 million milestone from Pfizer following the launch of the specialty drug Xiapex in Germany.


Biomarker Predicts Taxane-Induced Neuropathy

May 23, 2011 7:13 am | News | Comments

Researchers at Indiana University identified a genetic biomarker that causes neuropathy among breast cancer patients using taxanes.


Motorized Microscope Stage

May 23, 2011 5:40 am | Product Releases | Comments

Prior Scientific’s H117P2NN flat top stage for the Nikon Ti series of inverted microscopes,  can assist researchers conducting prolonged live cell studies.


Atomic-level Spectroscopy

May 23, 2011 5:31 am | Product Releases | Comments

FEI has extended its ChemiSTE Technology to enableatomic-level energy dispersive X-ray (EDX) spectroscopy across the periodic table.


Shire Receives Notice Letter from Sandoz

May 20, 2011 11:56 am | News | Comments

Shire LLC has received a Paragraph IV Notice Letter from Sandoz Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of all strengths of VYVANSE.


Logos and Medidata Partner

May 20, 2011 11:51 am | News | Comments

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, announced London-based Logos Technologies as a Medidata Technology Partner.


Stem Cell PCR Kit

May 20, 2011 11:47 am | Product Releases | Comments

AMSBIO has announced the launch of the PluriPCR Kit, a new benchmark to revolutionize the definition of stem cell pluripotency. The PluriPCR kit has been designed as a quantitative and reliable assay of five genes strongly specific to pluripotency.


Roller Bottle

May 20, 2011 11:41 am | Drug Discovery & Development | Product Releases | Comments

Greiner Bio-One North America, Inc. now offer the Cellmaster Roller Bottle product portfolio, designed to fulfill different requirements for the production of virus vaccines or recombinant proteins used for therapeutic approaches.


Regulators OK Extended Patient Treatment

May 20, 2011 11:34 am | News | Comments

TxCell SA announces the approval by AFSSAPS, the French regulatory agency, of its application to extend treatment of patients included in the Crohn’s Disease phase 1/2 study with Ovasave, a type 1 regulatory T cell based immunotherapy.


TM-400 Granted Orphan Drug Status

May 20, 2011 11:28 am | News | Comments

TikoMed AB announced that TM-400 has been granted orphan drug designation for treatment to mobilize progenitor cells prior to stem cell transplantation by the European Medicines Agency.


Pfizer's Eliquis Approved in Europe

May 20, 2011 11:24 am | News | Comments

Drugmaker Pfizer said that European regulators have approved its highly-anticipated blood thinner Eliquis to prevent blood clots in patients who have had hip or knee replacement surgery.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.